Welcome to Shanghai Probechem Biochemicals Co Ltd !Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : UCM1341
Catalog No.: PC-49841Not For Human Use, Lab Use Only.
UCM1341 (UCM 1341) is a bivalent ligand with melatonin receptor agonist (hMT1/hMT2, pKi=9.11/8.77) and fatty acid amide hydrolase (FAAH) inhibitory activity (rFAAH IC5=0.85 nM).
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | Get quote | ||
| 250 mg | Get quote | ||
| 500 mg | Get quote | ||
| 1 g | Get quote | ||
| 5 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
UCM1341 (UCM 1341) is a bivalent ligand with melatonin receptor agonist (hMT1/hMT2, pKi=9.11/8.77) and fatty acid amide hydrolase (FAAH) inhibitory activity (rFAAH IC5=0.85 nM).
UCM1341 exhibited greater neuroprotection against neuroinflammatory degeneration, compared with the reference compounds URB597 (FAAH inhibitor) and melatonin.
UCM1341 augmented the levels of anandamide and N-oleoylethanolamine, but not N-palmitoylethanolamine, up-regulated PPAR-α levels, attenuated demyelination and prevented the release of TNF-α, during neuroinflammation.
UCM1341 modulated inflammatory responses by contributing to microglia/macrophage polarization, stimulating formation of lipid-laden macrophages and regulating expression of proteins controlling cholesterol metabolism and efflux.
| M.Wt | 592.53 | |
| Formula | C31H34BrN3O4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Gilberto Spadoni, et al. J Med Chem. 2018 Sep 13;61(17):7902-7916.
2. Cammarota M, et al. Br J Pharmacol. 2022 Dec 16. doi: 10.1111/bph.16014.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
